Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motomu Hashimoto

Showing results (41-50 of 221) with videos related to

Pageof 23
Sort By:
Plos One|May 15, 2013
Neutrophils are essential as a source of IL-17 in the effector phase of arthritisMasaki Katayama, Koichiro Ohmura, Naoichiro Yukawa, et al.
Annals of the Rheumatic Diseases|August 21, 2019
Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factorYuki Ishikawa, Katsunori Ikari, Motomu Hashimoto, et al.
Journal of Clinical Medicine|March 17, 2025
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid ArthritisTasuku Togashi, Ryuhei Ishihara, Ryu Watanabe, et al.
Modern Rheumatology Case Reports|February 12, 2024
Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritisKazuo Fukumoto, Ryu Watanabe, Minako Tsutsumi, et al.
Lupus|March 28, 2026
Relationship between sarcopenia and lifestyle in patients with systemic lupus erythematosus: A one-institution cross-sectional analysisQi-Yun Dai, Yoshinari Matsumoto, Chisato Kawakami, et al.
Journal of Clinical Medicine|May 13, 2026
Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic InterceptionYukina Mizuno Yokoyama, Ryu Watanabe, Mayu Shiomi, et al.
Lupus|September 5, 2020
Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosusSeiko Kondo-Ishikawa, Takao Fujii, Nozomi Ishigooka, et al.
Plos One|July 23, 2013
Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritisKoichi Murata, Moritoshi Furu, Hiroyuki Yoshitomi, et al.
Internal Medicine (Tokyo, Japan)|June 1, 2022
Muscle Biopsy-proven Drug-induced Microscopic Polyangiitis in a Patient with TuberculosisGaku Kuwabara, Koichi Yamada, Kiyomi Tanaka, et al.
Modern Rheumatology|August 20, 2022
Management of sarcopenia in patients with rheumatoid arthritisMie Torii, Takahiro Itaya, Hiroto Minamino, et al.
Pageof 23

Showing results (41-50 of 221) with videos related to

Sort By:
Pageof 23
Plos One|May 15, 2013
Neutrophils are essential as a source of IL-17 in the effector phase of arthritisMasaki Katayama, Koichiro Ohmura, Naoichiro Yukawa, et al.
Annals of the Rheumatic Diseases|August 21, 2019
Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factorYuki Ishikawa, Katsunori Ikari, Motomu Hashimoto, et al.
Journal of Clinical Medicine|March 17, 2025
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid ArthritisTasuku Togashi, Ryuhei Ishihara, Ryu Watanabe, et al.
Modern Rheumatology Case Reports|February 12, 2024
Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritisKazuo Fukumoto, Ryu Watanabe, Minako Tsutsumi, et al.
Lupus|March 28, 2026
Relationship between sarcopenia and lifestyle in patients with systemic lupus erythematosus: A one-institution cross-sectional analysisQi-Yun Dai, Yoshinari Matsumoto, Chisato Kawakami, et al.
Journal of Clinical Medicine|May 13, 2026
Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic InterceptionYukina Mizuno Yokoyama, Ryu Watanabe, Mayu Shiomi, et al.
Lupus|September 5, 2020
Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosusSeiko Kondo-Ishikawa, Takao Fujii, Nozomi Ishigooka, et al.
Plos One|July 23, 2013
Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritisKoichi Murata, Moritoshi Furu, Hiroyuki Yoshitomi, et al.
Internal Medicine (Tokyo, Japan)|June 1, 2022
Muscle Biopsy-proven Drug-induced Microscopic Polyangiitis in a Patient with TuberculosisGaku Kuwabara, Koichi Yamada, Kiyomi Tanaka, et al.
Modern Rheumatology|August 20, 2022
Management of sarcopenia in patients with rheumatoid arthritisMie Torii, Takahiro Itaya, Hiroto Minamino, et al.
Pageof 23